CHRONIC AMPHETAMINE ADMINISTRATION IN SCHIZOPHRENIA

慢性精神分裂症中的缺陷症状对 治疗事实上，最常见的用于治疗精神分裂症的药物， 精神抑制剂，许多间接加强缺陷症状凭借 它们对所有多巴胺受体亚型的非特异性阻断。 本研究验证了以下假设： 精神分裂症患者被精神抑制剂“保护”可能会减少缺陷症状 而不会加重精神病症状

Deficit symptoms in chronic schizophrenia are particularly resistant to treatment. Indeed, the most common drugs used to treat schizophrenia, the neuroleptics, many indirectly intensify deficit symptoms by virtue of their non-specific blockade of all the subtypes of dopamine receptors. This study tests the hypothesis that the coadministration to schizophrenics "protected" by neuroleptic might reduce deficit symptoms without exacerbating psychotic symptoms.